Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept

Due to its abundant chondrogenic matrix and hypoxic tissue, chondrosarcoma is chemo- and radio-resistant. Our group has developed a proteoglycan targeting strategy by using a quaternary ammonium (QA) function as a carrier of DNA alkylating agents to chondrosarcoma environment. Here, we assessed the...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Oncotarget
Main Authors: Voissiere, Aurélien, Weber, Valérie, Gerard, Yvain, Rédini, Françoise, Raes, Florian, Chezal, Jean-Michel, Degoul, Françoise, Peyrode, Caroline, Miot-Noirault, Elisabeth
Formáid: Artigo
Teanga:Inglês
Foilsithe: Impact Journals LLC 2017
Ábhair:
Research Paper
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5707064/
https://ncbi.nlm.nih.gov/pubmed/29221170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21337
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla